Nonalcoholic fatty liver disease

Evangelia S. Makri, Stergios A. Polyzos

Antidiabetic drugs in patients with Covid-19 infection

Konstantinos Theocharis, Christina Antza, Georgios Kostopoulos, Vasilios Kotsis

Dietary Patterns and Cardiovascular Disease: A systematic review of 29 prospective studies with 1,249,644 participants, published in the last 20 years

Athanasia Karagiannidi, Aikaterini Kanellopoulou, Demosthenes Panagiotakos

Psychological factors and atherosclerotic cardiovascular disease development in women: A narrative review

Elpiniki Vlachopoulou, Christina Vassou, Demosthenes B. Panagiotakos

Metformin and type 2 diabetes in the era of cardiovascular outcome trials; A narrative review

Konstantinos Kitsios, Christina-Maria Trakatelli, Maria Sarigianni, Anastasia Kyriazidou, Fotios Aroutsidis, Konstantinos Mastrogiannis, Vasilios Kotsis

The role of dietary and physical activity assessment in the predictive ability of cardiovascular disease risk scores: A narrative review

Christina Vafia, Demosthenes Panagiotakos

An overview of the effects of combination therapy with a renin-angiotensin system blocker plus a calcium channel blocker on glucose homeostasis in non-diabetic hypertensive patients

Angelos Liontos, Dimitrios Biros, George Liamis, Haralampos Milionis

Prevalence of Type 2 Diabetes and Cardiometabolic Risk Parameters in Evros

Sarantoula Ventouri, Nikolaos Papanas, Stylianos Tigas, Christos Nalmpantis, Efstratios Maltezos, Agathocles Tsatsoulis

Genetics of severe hypercholesterolemia in the general population: Insights from the STANISLAS cohort

Constance Xhaard, João Pedro Ferreira, Edith Le Floch, Zohra Lamiral, Claire Dandine-Roulland, Delphine Bacq-Daian, Erwan Bozec, Jean-Marc Boivin, Nicolas Girerd, Jean-François Deleuze, Faiez Zannad, Patrick Rossignol